Abstract
Multipoint pacing (MPP) may improve outcomes of patient undergoing cardiac resynchronisation therapy (CRT), however the impact on projected battery longevity (PBL) in a randomised controlled trial (RCT) is unclear. The MPP VARR study aims to determine if MPP results in a greater response in patients receiving CRT with MPP (MPP-ON) when compared to conventional CRT (MPP-OFF).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
